Ryan T Muir1, Benjamin Lam1, Kie Honjo1, Robin D Harry1, Alicia A McNeely1, Fu-Qiang Gao1, Joel Ramirez1, Christopher J M Scott1, Anoop Ganda1, Jiali Zhao1, X Joe Zhou1, Simon J Graham1, Novena Rangwala1, Erin Gibson1, Nancy J Lobaugh1, Alex Kiss1, Donald T Stuss1, David L Nyenhuis1, Byung-Chul Lee1, Yeonwook Kang1, Sandra E Black2. 1. From the L.C. Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre (R.T.M., B.L., K.H., R.D.H., A.A.M., F.-Q.G., J.R., C.J.M.S., A.G., J.Z., S.E.B.), Heart and Stroke Foundation Centre for Stroke Recovery, Sunnybrook Health Sciences Centre (R.T.M., B.L., K.H., R.D.H., A.A.M., F.-Q.G., J.R., C.J.M.S., A.G., J.Z., E.G., S.E.B.), Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute (R.T.M., B.L., K.H., R.D.H., A.A.M., F.-Q.G., J.R., C.J.M.S., A.G., J.Z., S.J.G., E.G., D.T.S., S.E.B.), Department of Medicine, Division of Neurology (R.T.M., B.L., K.H., R.D.H., A.A.M., F.Q.G., J.R., C.J.M.S., A.G., J.Z., E.G., N.J.L , D.T.S., S.E.B.), Department of Medical Biophysics (S.J.G.), Rotman Research Institute, Baycrest (D.T.S., S.E.B.), and Department of Research Design and Biostatistics, Sunnybrook Health Sciences Centre (A.K.), University of Toronto, Toronto, ON, Canada; Departments of Radiology, Neurosurgery, and Bioengineering (X.J.Z.), and Department of Clinical Neuropsychology (N.R., D.L.N.), College of Medicine at Chicago, University of Illinois; Hauenstein Neuroscience Center, Saint Mary's Health Care, Grand Rapids, MI (N.R., D.L.N.); Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada (N.J.L.); Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, South Korea (B.-C.L., Y.K.); Department of Psychology, Hallym University, Chuncheon, South Korea (Y.K.); and Heart and Stroke Foundation Canadian Partnership for Stroke Recovery (K.H., S.E.B.). 2. From the L.C. Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre (R.T.M., B.L., K.H., R.D.H., A.A.M., F.-Q.G., J.R., C.J.M.S., A.G., J.Z., S.E.B.), Heart and Stroke Foundation Centre for Stroke Recovery, Sunnybrook Health Sciences Centre (R.T.M., B.L., K.H., R.D.H., A.A.M., F.-Q.G., J.R., C.J.M.S., A.G., J.Z., E.G., S.E.B.), Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute (R.T.M., B.L., K.H., R.D.H., A.A.M., F.-Q.G., J.R., C.J.M.S., A.G., J.Z., S.J.G., E.G., D.T.S., S.E.B.), Department of Medicine, Division of Neurology (R.T.M., B.L., K.H., R.D.H., A.A.M., F.Q.G., J.R., C.J.M.S., A.G., J.Z., E.G., N.J.L , D.T.S., S.E.B.), Department of Medical Biophysics (S.J.G.), Rotman Research Institute, Baycrest (D.T.S., S.E.B.), and Department of Research Design and Biostatistics, Sunnybrook Health Sciences Centre (A.K.), University of Toronto, Toronto, ON, Canada; Departments of Radiology, Neurosurgery, and Bioengineering (X.J.Z.), and Department of Clinical Neuropsychology (N.R., D.L.N.), College of Medicine at Chicago, University of Illinois; Hauenstein Neuroscience Center, Saint Mary's Health Care, Grand Rapids, MI (N.R., D.L.N.); Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada (N.J.L.); Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, South Korea (B.-C.L., Y.K.); Department of Psychology, Hallym University, Chuncheon, South Korea (Y.K.); and Heart and Stroke Foundation Canadian Partnership for Stroke Recovery (K.H., S.E.B.). sandra.black@sunnybrook.ca ykang@hallym.ac.kr.
Abstract
BACKGROUND AND PURPOSE: Poststroke cognitive impairment is typified by prominent deficits in processing speed and executive function. However, the underlying neuroanatomical substrates of executive deficits are not well understood, and further elucidation is needed. There may be utility in fractionating executive functions to delineate neural substrates. METHODS: One test amenable to fine delineation is the Trail Making Test (TMT), which emphasizes processing speed (TMT-A) and set shifting (TMT-B-A difference, proportion, quotient scores, and TMT-B set-shifting errors). The TMT was administered to 2 overt ischemic stroke cohorts from a multinational study: (1) a chronic stroke cohort (N=61) and (2) an acute-subacute stroke cohort (N=45). Volumetric quantification of ischemic stroke and white matter hyperintensities was done on magnetic resonance imaging, along with ratings of involvement of cholinergic projections, using the previously published cholinergic hyperintensities projections scale. Damage to the superior longitudinal fasciculus, which colocalizes with some cholinergic projections, was also documented. RESULTS: Multiple linear regression analyses were completed. Although larger infarcts (β=0.37, P<0.0001) were associated with slower processing speed, cholinergic hyperintensities projections scale severity (β=0.39, P<0.0001) was associated with all metrics of set shifting. Left superior longitudinal fasciculus damage, however, was only associated with the difference score (β=0.17, P=0.03). These findings were replicated in both cohorts. Patients with ≥2 TMT-B set-shifting errors also had greater cholinergic hyperintensities projections scale severity. CONCLUSIONS: In this multinational stroke cohort study, damage to lateral cholinergic pathways and the superior longitudinal fasciculus emerged as significant neuroanatomical correlates for executive deficits in set shifting.
BACKGROUND AND PURPOSE:Poststroke cognitive impairment is typified by prominent deficits in processing speed and executive function. However, the underlying neuroanatomical substrates of executive deficits are not well understood, and further elucidation is needed. There may be utility in fractionating executive functions to delineate neural substrates. METHODS: One test amenable to fine delineation is the Trail Making Test (TMT), which emphasizes processing speed (TMT-A) and set shifting (TMT-B-A difference, proportion, quotient scores, and TMT-B set-shifting errors). The TMT was administered to 2 overt ischemic stroke cohorts from a multinational study: (1) a chronic stroke cohort (N=61) and (2) an acute-subacute stroke cohort (N=45). Volumetric quantification of ischemic stroke and white matter hyperintensities was done on magnetic resonance imaging, along with ratings of involvement of cholinergic projections, using the previously published cholinergic hyperintensities projections scale. Damage to the superior longitudinal fasciculus, which colocalizes with some cholinergic projections, was also documented. RESULTS: Multiple linear regression analyses were completed. Although larger infarcts (β=0.37, P<0.0001) were associated with slower processing speed, cholinergic hyperintensities projections scale severity (β=0.39, P<0.0001) was associated with all metrics of set shifting. Left superior longitudinal fasciculus damage, however, was only associated with the difference score (β=0.17, P=0.03). These findings were replicated in both cohorts. Patients with ≥2 TMT-B set-shifting errors also had greater cholinergic hyperintensities projections scale severity. CONCLUSIONS: In this multinational stroke cohort study, damage to lateral cholinergic pathways and the superior longitudinal fasciculus emerged as significant neuroanatomical correlates for executive deficits in set shifting.
Keywords:
Trail Making Test; cholinergic pathways; executive functions; processing speed; set shifting; superior longitudinal fasciculus; white matter hyperintensities
Authors: Benjamin Kolisnyk; Mohammed A Al-Onaizi; Pedro H F Hirata; Monica S Guzman; Simona Nikolova; Shahar Barbash; Hermona Soreq; Robert Bartha; Marco A M Prado; Vania F Prado Journal: J Neurosci Date: 2013-09-11 Impact factor: 6.167
Authors: Christian Bocti; Richard H Swartz; Fu-Qiang Gao; Demetrios J Sahlas; Pearl Behl; Sandra E Black Journal: Stroke Date: 2005-09-22 Impact factor: 7.914
Authors: K Narasimhalu; S Ang; D A De Silva; M-C Wong; H-M Chang; K-S Chia; A P Auchus; C Chen Journal: Neurology Date: 2009-12-01 Impact factor: 9.910
Authors: David S Knopman; Rosebud O Roberts; Yonas E Geda; Bradley F Boeve; V Shane Pankratz; Ruth H Cha; Eric G Tangalos; Robert J Ivnik; Ronald C Petersen Journal: Arch Neurol Date: 2009-05
Authors: G Andrew James; Tonisha E Kearney-Ramos; Jonathan A Young; Clinton D Kilts; Jennifer L Gess; Jennifer S Fausett Journal: Brain Cogn Date: 2016-04-20 Impact factor: 2.310
Authors: Elizabeth H Lacey; Laura M Skipper-Kallal; Shihui Xing; Mackenzie E Fama; Peter E Turkeltaub Journal: Neurorehabil Neural Repair Date: 2017-01-30 Impact factor: 3.919
Authors: Paul Rinne; Mursyida Hassan; Cristina Fernandes; Erika Han; Emma Hennessy; Adam Waldman; Pankaj Sharma; David Soto; Robert Leech; Paresh A Malhotra; Paul Bentley Journal: Proc Natl Acad Sci U S A Date: 2017-12-28 Impact factor: 11.205
Authors: Calvin Santiago; Nathan Herrmann; Walter Swardfager; Mahwesh Saleem; Paul I Oh; Sandra E Black; Janelle Bradley; Krista L Lanctôt Journal: Int J Geriatr Psychiatry Date: 2017-05-05 Impact factor: 3.485
Authors: Elena López-Cancio; Tudor G Jovin; Erik Cobo; Neus Cerdá; Marta Jiménez; Meritxell Gomis; María Hernández-Pérez; Cynthia Cáceres; Pere Cardona; Blanca Lara; Arturo Renú; Laura Llull; Sandra Boned; Marian Muchada; Antoni Dávalos Journal: Neurology Date: 2016-12-09 Impact factor: 9.910
Authors: Zhongmin Lin; Fred Tam; Nathan W Churchill; Fa-Hsuan Lin; Bradley J MacIntosh; Tom A Schweizer; Simon J Graham Journal: Front Hum Neurosci Date: 2021-07-01 Impact factor: 3.169
Authors: Jessica Peter; Jacob Lahr; Lora Minkova; Eliza Lauer; Michel J Grothe; Stefan Teipel; Lena Köstering; Christoph P Kaller; Bernhard Heimbach; Michael Hüll; Claus Normann; Christoph Nissen; Janine Reis; Stefan Klöppel Journal: J Alzheimers Dis Date: 2016-06-18 Impact factor: 4.472
Authors: Sarah E MacPherson; Simon R Cox; David A Dickie; Sherif Karama; John M Starr; Alan C Evans; Mark E Bastin; Joanna M Wardlaw; Ian J Deary Journal: Cortex Date: 2017-08-09 Impact factor: 4.027